Short-Term Cocaine Treatment Causes Neuroadaptive Changes in Gαq and Gα11 Proteins in Rats Undergoing Withdrawal

One of the characteristics of drug dependence is that a drug has to be administered repeatedly before withdrawal effects can be observed. We have previously shown that withdrawal after 14 days of cocaine treatment produces a supersensitivity of hypothalamic 5-hydroxytryptamine (serotonin) 2A (5-HT 2...

Full description

Saved in:
Bibliographic Details
Published inThe Journal of pharmacology and experimental therapeutics Vol. 311; no. 1; p. 349
Main Authors Gonzalo A. Carrasco, Katerina J. Damjanoska, Deborah N. D'Souza, Yahong Zhang, Francisca Garcia, George Battaglia, Nancy A. Muma, Louis D. Van de Kar
Format Journal Article
LanguageEnglish
Published American Society for Pharmacology and Experimental Therapeutics 01.10.2004
Online AccessGet full text

Cover

Loading…
Abstract One of the characteristics of drug dependence is that a drug has to be administered repeatedly before withdrawal effects can be observed. We have previously shown that withdrawal after 14 days of cocaine treatment produces a supersensitivity of hypothalamic 5-hydroxytryptamine (serotonin) 2A (5-HT 2A ) receptors, which is accompanied by increases in the levels of Gα q and Gα 11 proteins. Unfortunately, the exact duration of cocaine treatment necessary to induce alterations in G protein levels during cocaine withdrawal is unknown. The present study investigated the minimum cocaine treatment period required to produce changes in protein levels of membrane- and cytosol-associated Gα q and Gα 11 proteins in the hypothalamic paraventricular nucleus, amygdala, and frontal cortex. Rats were injected with cocaine (15 mg/kg i.p., b.i.d.) for 0, 1, 3, 5, and 7 days and tested after 2 days of withdrawal. The levels of Gα q and Gα 11 proteins were increased in the paraventricular nucleus and the amygdala but not in the frontal cortex. Although 1 and 3 days of cocaine treatment were sufficient to maximally elevate the protein levels of Gα 11 and Gα q proteins in the amygdala, 5 days of treatment were required to maximally increase the levels of Gα 11 and Gα q proteins in the paraventricular nucleus. The data suggest that the amygdala shows a faster neuroadaptation to the effects of cocaine than the hypothalamic paraventricular nucleus. These findings provide insight into the relative importance of individual components of 5-HT 2A receptor signal transduction system in regulating the overall sensitivity of this signaling in cocaine-treated rats.
AbstractList One of the characteristics of drug dependence is that a drug has to be administered repeatedly before withdrawal effects can be observed. We have previously shown that withdrawal after 14 days of cocaine treatment produces a supersensitivity of hypothalamic 5-hydroxytryptamine (serotonin) 2A (5-HT 2A ) receptors, which is accompanied by increases in the levels of Gα q and Gα 11 proteins. Unfortunately, the exact duration of cocaine treatment necessary to induce alterations in G protein levels during cocaine withdrawal is unknown. The present study investigated the minimum cocaine treatment period required to produce changes in protein levels of membrane- and cytosol-associated Gα q and Gα 11 proteins in the hypothalamic paraventricular nucleus, amygdala, and frontal cortex. Rats were injected with cocaine (15 mg/kg i.p., b.i.d.) for 0, 1, 3, 5, and 7 days and tested after 2 days of withdrawal. The levels of Gα q and Gα 11 proteins were increased in the paraventricular nucleus and the amygdala but not in the frontal cortex. Although 1 and 3 days of cocaine treatment were sufficient to maximally elevate the protein levels of Gα 11 and Gα q proteins in the amygdala, 5 days of treatment were required to maximally increase the levels of Gα 11 and Gα q proteins in the paraventricular nucleus. The data suggest that the amygdala shows a faster neuroadaptation to the effects of cocaine than the hypothalamic paraventricular nucleus. These findings provide insight into the relative importance of individual components of 5-HT 2A receptor signal transduction system in regulating the overall sensitivity of this signaling in cocaine-treated rats.
Author Nancy A. Muma
Louis D. Van de Kar
Francisca Garcia
Katerina J. Damjanoska
George Battaglia
Deborah N. D'Souza
Gonzalo A. Carrasco
Yahong Zhang
Author_xml – sequence: 1
  fullname: Gonzalo A. Carrasco
– sequence: 2
  fullname: Katerina J. Damjanoska
– sequence: 3
  fullname: Deborah N. D'Souza
– sequence: 4
  fullname: Yahong Zhang
– sequence: 5
  fullname: Francisca Garcia
– sequence: 6
  fullname: George Battaglia
– sequence: 7
  fullname: Nancy A. Muma
– sequence: 8
  fullname: Louis D. Van de Kar
BookMark eNqNikFOwzAQRS1URFNgzdYrdkk9sZPSdQR0hVAJYhmNmiF2ldjBdltxCe7CFeBiIOAArP7Te3_GJtZZYuwCRAaQq_l2pJiBUJkol1diccQSKHJIBQg5YYkQeZ7KoiymbBbCVghQqpQnbAoFLAqVy4TtH7TzMa3JD7xyGzSWeO0J40A28gp3gQK_o5132OIYzZ54pdF239ZYfvv59vH-wtG2vwjA772LZOxPXmMM_NG25DtnbMefTNStxwP2Z-z4GftA5397yi5vrutqlWrT6YPx1Iwa_YAb17vutZEADTRSLeW_j19_S1u_
ContentType Journal Article
DOI 10.1124/jpet.104.069807
DatabaseTitleList
DeliveryMethod fulltext_linktorsrc
Discipline Pharmacy, Therapeutics, & Pharmacology
EISSN 1521-0103
ExternalDocumentID 311_1_349
GroupedDBID -
08R
0R
2WC
3O-
4.4
53G
55
5GY
5RE
8RP
AALRV
ABFLS
ABIVO
ABOCM
ABSGY
ABZEH
ACDCL
ACGFS
ACNCT
ADACO
ADBIT
ADCOW
ADKFC
AENEX
AETEA
AFFNX
AIKQT
ALMA_UNASSIGNED_HOLDINGS
CS3
DIK
DL
DU5
E3Z
EBS
EJD
F5P
FH7
GJ
GX1
H13
HZ
INIJC
KQ8
L7B
LSO
O0-
O9-
OHT
OK1
P2P
R.V
R0Z
RHF
RHI
RPT
W2D
WH7
WOQ
X
X7M
ZGI
ZXP
ID FETCH-highwire_pharmacology_311_1_3493
ISSN 0022-3565
IngestDate Tue Jan 05 21:16:48 EST 2021
IsPeerReviewed true
IsScholarly true
Issue 1
Language English
LinkModel OpenURL
MergedId FETCHMERGED-highwire_pharmacology_311_1_3493
PMID 15175423
ParticipantIDs highwire_pharmacology_311_1_349
ProviderPackageCode RHF
RHI
PublicationCentury 2000
PublicationDate 20041001
PublicationDateYYYYMMDD 2004-10-01
PublicationDate_xml – month: 10
  year: 2004
  text: 20041001
  day: 01
PublicationDecade 2000
PublicationTitle The Journal of pharmacology and experimental therapeutics
PublicationYear 2004
Publisher American Society for Pharmacology and Experimental Therapeutics
Publisher_xml – name: American Society for Pharmacology and Experimental Therapeutics
SSID ssj0014463
Score 3.5702155
Snippet One of the characteristics of drug dependence is that a drug has to be administered repeatedly before withdrawal effects can be observed. We have previously...
SourceID highwire
SourceType Publisher
StartPage 349
Title Short-Term Cocaine Treatment Causes Neuroadaptive Changes in Gαq and Gα11 Proteins in Rats Undergoing Withdrawal
URI http://jpet.aspetjournals.org/content/311/1/349.abstract
Volume 311
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb9MwFLa28cIL4iru-IH2gS4htybp41aVTnuYEAuiPFVu4q4bLOnSBER_xP7L_sL4Y5xju45bkAa8JJETJbbPdy6xz4WQ11GUec407VohqGcrCMOJNen5ocXjiHFQB6GTCgfZo_DgY3A46o62tt8YXkt1NbHT5R_jSv6HqtAGdMUo2X-grH4pNMA10BeOQGE4_hWNj2dgPFsJCFfg65ShwZhox_E-qxccpVhdFixjc-EjJIMJhA_sEPfI40Gr77X23QuxibDW5LoYRYDFMMXjH1iFvjQZL08KXF74dFrNspJ9V308a1Bn2LjzJjG2zPO0VlDAiP3Slv2wyJfsa9HZs9EXpWSLtNA6gWFe6Zx1Dm0A6_kZy4vFF61VlODsHMHNlhcdF_VS3_vMZlhSSSyOry1zBNphrjIiC1DkGc6s7zcHMTAHkWwOwgxfkAUqbK6kvodrKo5vqgVfKQET_1LI-zLJ6u_KxwtQ-cDfDu6c207Yi2VFXwOK83OBRbCzsPSw32jhlefBhnLWLpPQnbE7hk9vk1seCFWU5sORdmfC33pfZ8aH4ak0VtCntxs9EpWo5OeNrNiGVZXcJXcUVOiexPY9ssXz-6StZvzHLjVnd5e2qUmLB-RbwwBUMQDVDEAlA9A1BqCKAehpToc_L6-vLihQVF66Ll0BHm8j4GkDeNoA_iFpvxsk_QNrNaqxifOxnkP_EdnJi5w_JjTNsh5z0pjz2AlSlsVBN55GcHKCaDoN2BPy6oaXPb3xiWfkdgPp52SnKmv-AmzZavJSEPEXM4erGA
link.rule.ids 315,783,787,27936,27937
linkProvider Geneva Foundation for Medical Education and Research
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Short-Term+Cocaine+Treatment+Causes+Neuroadaptive+Changes+in+G%C3%8E%C2%B1q+and+G%C3%8E%C2%B111+Proteins+in+Rats+Undergoing+Withdrawal&rft.jtitle=The+Journal+of+pharmacology+and+experimental+therapeutics&rft.au=Gonzalo+A.+Carrasco&rft.au=Katerina+J.+Damjanoska&rft.au=Deborah+N.+D%27Souza&rft.au=Yahong+Zhang&rft.date=2004-10-01&rft.pub=American+Society+for+Pharmacology+and+Experimental+Therapeutics&rft.issn=0022-3565&rft.eissn=1521-0103&rft.volume=311&rft.issue=1&rft.spage=349&rft_id=info:doi/10.1124%2Fjpet.104.069807&rft_id=info%3Apmid%2F15175423&rft.externalDBID=n%2Fa&rft.externalDocID=311_1_349
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0022-3565&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0022-3565&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0022-3565&client=summon